Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.83 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.83 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.83 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.83 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.83 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.83 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.83 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.83 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.83 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.83 |
| ▸ | PSMB4 | P28070 | 2/20 | 0.83 |
| ▸ | PSMB6 | P28072 | 2/20 | 0.83 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.83 |
| ▸ | PSMB10 | P40306 | 2/20 | 0.83 |
| ▸ | PSMB3 | P49720 | 2/20 | 0.83 |
| ▸ | PSMB2 | P49721 | 2/20 | 0.83 |
| ▸ | PSMA6 | P60900 | 2/20 | 0.83 |
| ▸ | PSMA8 | Q8TAA3 | 2/20 | 0.83 |
| ▸ | PSMB7 | Q99436 | 2/20 | 0.83 |
| ▸ | CNR1 | P21554 | 5/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7271399 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL7262780 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL39445 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL38999 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL2720795 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL1133530 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL39282 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL13510734 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL7264242 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL7270436 | 1.00 | PSMB11 (0.83) | PSMB11PSMA7PSMB1PSMA1PSMA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332001-A1 | SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF ACYL-PARA-AMINOPHENOL DERIVATIVES | MONTEFIORE MEDICAL CENTER | 2021-10-28 | — | — | US | claimed |
| EP-0091519-B1 | TOPICAL ACYLAMINOPHENOLS | Johnson & Johnson Products Inc. (US) | 1987-06-24 | — | — | EP | claimed |
| EP-0091519-A1 | Topical acylaminophenols | Johnson & Johnson Products Inc. (US) | 1983-10-19 | — | — | EP | claimed |
| US-4329366-A | ANTIINFLAMMATORY AGENTS | JOHNSON & JOHNSON PRODUCTS, INC. (US) | 1982-05-11 | — | — | US | claimed |
| US-20210332001-A1 | SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF ACYL-PARA-AMINOPHENOL DERIVATIVES | MONTEFIORE MEDICAL CENTER | 2021-10-28 | — | — | US | disclosed |
| US-20210332001-A1 | SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF ACYL-PARA-AMINOPHENOL DERIVATIVES | MONTEFIORE MEDICAL CENTER | 2021-10-28 | — | — | US | disclosed |
| US-8987226-B2 | Modified single-stranded polynucleotides | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-03-24 | — | — | US | disclosed |
| US-6004899-A | SURFACE TREATED WITH SILANE, TITANATE, AND/OR ALUMINUM COUPLING AGENT; PIGMENT; ERASIBILITY | MITSUBISHI PAPER MILLS LIMITED (JP) | 1999-12-21 | — | — | US | disclosed |
| EP-0574879-B1 | Reversible heat-sensitive recording material | MITSUBISHI PAPER MILLS LTD (JP) | 1997-05-02 | — | — | EP | disclosed |
| US-5395815-A | Phenolic compound electron acceptor; images; contrast; stability | MITSUBISHI PAPER MILLS LIMITED (JP) | 1995-03-07 | — | — | US | disclosed |
| EP-0574879-A1 | Reversible heat-sensitive recording material | MITSUBISHI PAPER MILLS, LTD. (JP) | 1993-12-22 | — | — | EP | disclosed |
| EP-0091519-B1 | TOPICAL ACYLAMINOPHENOLS | Johnson & Johnson Products Inc. (US) | 1987-06-24 | — | — | EP | disclosed |
| EP-0091519-A1 | Topical acylaminophenols | Johnson & Johnson Products Inc. (US) | 1983-10-19 | — | — | EP | disclosed |
| US-4329366-A | ANTIINFLAMMATORY AGENTS | JOHNSON & JOHNSON PRODUCTS, INC. (US) | 1982-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332001-A1 | SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF ACYL-PARA-AMINOPHENOL DERIVATIVES | AADAC, FABP7, NPEPPS | PSMB11 1050/4885PSMA7 678/4885PSMB1 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.